Henoch-Schonlein Purpura - Sally Daughtrey, ND (2021 Conference) (LDN, low dose naltrexone)

 

Henoch-Schonlein Purpura - Sally Daughtrey, ND (2021 Conference) (LDN, low dose naltrexone)

In her presentation, Dr. Daughtry explains Henoch-Schonlein (HSP), its triggers and complications (such as serious hidden infections often missed initially), and the use of Low Dose Naltrexone in treating HSP. Dr. Daughtry gives an in-depth look into one pediatric case she treated successfully with LDN.

Keywords: Low Dose Naltrexone, LDN, Henoch-Schonlein Purpura, HSP, infection, mold toxicity, autoimmune disease, lesions, rash, IGA vasculitis, propura rhematica, joint pain, kidney damage, acute infection, renal function, rheumatoid arthritis, immune activation, immune system, hives, abdominal pain, Cat Scratch Fever, Bartonella henselae infection, Bartonella, immune suppression, acute infection, chronic infection, neurological symptoms, tics, anxiety, OCD, insomnia, pediatric acute onset neuropsychiatric syndrome, PANS, depression, irritability, aggression, oppositional behavior, developmental regression, urinary frequency, steroids, mold allergy, pain

This is a summary of the presentation. Click on the video for full information.